BioCardia, Inc. Common Stock
£0.67404
GBP
Last updated on --.
24h volume49.67K
24h highest0.72246 GBP
24h lowest0.66883 GBP
24h Price movement-0.67%
BCDA recent prices
24 Hours
-0.67%-£0.0045433
30 days
-20.61%-£0.17503
60 days
-21.98%-£0.18992
90 days
-29.85%-£0.28675
Key data
Previous close0.67859 GBP
Market cap7.79M GBP
Volume49.67K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.50646 GBP
Net income (FY)-5.79M GBP
Revenue (FY)--
Last report dateMay 15, 2026
About BioCardia, Inc. Common Stock
HeadquartersSUNNYVALE
Employees (FY)21.00
Net income per employee (FY)-275.75K GBP
Listed onNasdaq
BCDA conversion tables
 |  |
|---|---|
| 0.5 BCDA | 0.33702 GBP |
| 1 BCDA | 0.67404 GBP |
| 5 BCDA | 3.370 GBP |
| 10 BCDA | 6.740 GBP |
| |
|---|---|
| 0.5 GBP | 0.74179 BCDA |
| 1 GBP | 1.483 BCDA |
| 5 GBP | 7.417 BCDA |
| 10 GBP | 14.83 BCDA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BCDA is trading at £0.67404, -0.67% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BCDA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BCDA is currently trading at £0.67404, -0.67% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BCDA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BCDA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BCDA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BCDA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
BioCardia, Inc. Common Stock's market cap is currently 7.79M GBP. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume49.67K
24h highest0.72246 GBP
24h lowest0.66883 GBP
24h Price movement-0.67%
Start trade with BCDA Perpetual
Sign up to trade